glp 1 is not working for me GLP-1 Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 Medications: Everything You Need

In a research letter published in JAMA Network Open in August, the authors purchased off-brand forms of semaglutide from six online pharmacies

A comprehensive meta-analysis, including SOUL trial data, demonstrated that long-acting GLP-1 RAs reduce the incidence of major adverse cardiovascular events (MACEs), hospitalization for heart failure, kidney events, and all-cause mortality in type 2 diabetes [66]

2025 ( Obesity Pillars ), 461,382 GLP-1 users: 22% new nutritional deficiency by 12 months, muscle loss diagnoses increasing over time

Exendin-4 Induces a Novel Extended Effect of Ischemic Tolerance via Crosstalk With IGF-1r

Alexandra Sowa, MD of SoWell Health, who is a board certified obesity medicine expert and a clinical instructor of medicine at NYU, explained that its not surprising that a drug used to treat diabetes and obesity might also affect alcohol use disorder

The semaglutide versus tirzepatide comparison is detailed and nuanced, with differences in side effect profiles, dosing convenience, and insurance coverage all playing a role